Bridgewater Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$713K Buy
2,560
+14
+0.5% +$4.16K 0.04% 187
2025
Q4
$677K Buy
2,546
+20
+0.8% +$5.43K 0.04% 204
2025
Q3
$668K Buy
2,526
+4
+0.2% +$1.09K 0.05% 192
2025
Q2
$676K Buy
2,522
+128
+5% +$34.8K 0.05% 191
2025
Q1
$652K Buy
+2,394
New +$591K 0.06% 183
2022
Q3
Sell
-1,342
Closed -$275K 145
2022
Q2
$275K Sell
1,342
-68
-5% -$14.4K 0.06% 193
2022
Q1
$335K Buy
1,410
+109
+8% +$25.6K 0.08% 179
2021
Q4
$297K Buy
1,301
+36
+3% +$7.92K 0.07% 199
2021
Q3
$245K Buy
1,265
+15
+1% +$3.04K 0.07% 211
2021
Q2
$266K Sell
1,250
-30
-2% -$6.33K 0.08% 196
2021
Q1
$274K Buy
+1,280
New +$252K 0.14% 130

Other funds holding CME

Bridgewater Advisors's CME Position: Q1 2026 in Review

Bridgewater Advisors increased its CME Group (CME) stake by 0.55% in Q1 2026, buying an estimated $4.16K and bringing the position to 2,560 shares worth $713K. The position accounts for 0.04% of the portfolio, ranked #187.

Bridgewater Advisors first reported a position in CME in Q1 2021 and has held it in 11 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Bridgewater Advisors held 2,560 shares of CME Group worth $713K as of Q1 2026.
  • Bridgewater Advisors bought 14 CME Group shares in Q1 2026, an estimated $4.16K.
  • CME Group made up 0.04% of Bridgewater Advisors's portfolio in Q1 2026, its #187 holding.
  • Bridgewater Advisors first reported a position in CME Group in Q1 2021 and has held it in 11 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.